About
Monoclonal Antibodies
Areas of Focus
Categories
Biologics & BiopharmaceuticalAntibody
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
67
By Phase
PHASE2: 2PHASE1: 1
By Status
COMPLETED: 2RECRUITING: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06225843Lead Sponsor
Sotevtamab (AB-16B5) Combined With FOLFOX as Neoadjuvant Treatment Prior to Resection of Colorectal Cancer Liver Metastasis
PHASE2Recruiting
17 participants
Started: Feb 15, 2024 · Completed: Jun 30, 2026
NCT04364620Lead Sponsor
AB-16B5 Combined With Docetaxel in Subjects With Metastatic Non-Small Cell Lung Cancer (EGIA-002)
PHASE2Completed
35 participants
Started: Feb 23, 2021 · Completed: Dec 31, 2023
NCT02412462Lead Sponsor
Phase I Dose Escalation Study of AB-16B5 in Subjects With an Advanced Solid Malignancy
PHASE1Completed
15 participants
Started: Apr 30, 2015 · Completed: Jan 31, 2017
Locations (1)
Headquarters
Montréal, QC, Canada
Map
Loading map...